Denosumab

Red

Brand Name(s):Prolia

Indication:Hypercalcaemia for patients resistent to Zolendronate

Rationale:1,2

Considered:Jan-15

Review Date:Jun-22

Comments:
Drug Safety Update
Denosumab is associated with a risk of osteonecrosis of the jaw, osteonecrosis of the external auditory canal has also been reported with denosumab
June 2017